カテゴリ： QYResearch, 世界, 医療/バイオ

4因子プロトロンビン複合体濃縮物の世界市場2025年：Beriplex、Octaplex、Prothromplex、Cofact、その他

■ 英語タイトル：Global 4 Factor Pro-thrombin Complex Concentrate Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8650）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8650
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：74
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[4因子プロトロンビン複合体濃縮物の世界市場2025年：Beriplex、Octaplex、Prothromplex、Cofact、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は4因子プロトロンビン複合体濃縮物のグローバル市場について調査・分析し、世界の4因子プロトロンビン複合体濃縮物市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（Beriplex、Octaplex、Prothromplex、Cofact、その他）、用途別セグメント分析（血友病B、後天性凝固因子欠損症）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、CSL Behring、Octapharma、Prothya Biosolutions、Takedaなどが含まれています。4因子プロトロンビン複合体濃縮物のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、4因子プロトロンビン複合体濃縮物市場規模を算出する際に考慮しました。

・4因子プロトロンビン複合体濃縮物市場の概要
- 製品の定義
- 4因子プロトロンビン複合体濃縮物の種類別セグメント
- 世界の4因子プロトロンビン複合体濃縮物市場規模：タイプ別分析（Beriplex、Octaplex、Prothromplex、Cofact、その他）
- 4因子プロトロンビン複合体濃縮物の用途別セグメント
- 世界の4因子プロトロンビン複合体濃縮物市場規模：用途別分析（血友病B、後天性凝固因子欠損症）
- 世界の4因子プロトロンビン複合体濃縮物市場規模予測（2020年-2031年）
- 4因子プロトロンビン複合体濃縮物の平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 4因子プロトロンビン複合体濃縮物市場の競争状況およびトレンド

・4因子プロトロンビン複合体濃縮物の地域別市場規模
- 北米の4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- 米国の4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- ヨーロッパの4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- アジア太平洋の4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- 中国の4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- 日本の4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- 韓国の4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- インドの4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- オーストラリアの4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- 中南米の4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）
- 中東・アフリカの4因子プロトロンビン複合体濃縮物市場規模（2020年-2031年）

・種類別セグメント：Beriplex、Octaplex、Prothromplex、Cofact、その他
- 世界の4因子プロトロンビン複合体濃縮物のタイプ別販売量（2020年-2025年）
- 世界の4因子プロトロンビン複合体濃縮物のタイプ別売上（2020年-2025年）
- 世界の4因子プロトロンビン複合体濃縮物のタイプ別価格

・用途別セグメント：血友病B、後天性凝固因子欠損症
- 世界の4因子プロトロンビン複合体濃縮物の用途別販売量（2020年-2025年）
- 世界の4因子プロトロンビン複合体濃縮物の用途別売上（2020年-2025年）
- 世界の4因子プロトロンビン複合体濃縮物の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
CSL Behring、Octapharma、Prothya Biosolutions、Takeda

・産業チェーンと販売チャネルの分析
- 4因子プロトロンビン複合体濃縮物産業チェーン分析
- 4因子プロトロンビン複合体濃縮物の主要原材料
- 4因子プロトロンビン複合体濃縮物の販売チャネル
- 4因子プロトロンビン複合体濃縮物のディストリビューター
- 4因子プロトロンビン複合体濃縮物の主要顧客

・4因子プロトロンビン複合体濃縮物市場ダイナミクス
- 4因子プロトロンビン複合体濃縮物の業界動向
- 4因子プロトロンビン複合体濃縮物市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

The 4-factor prothrombin complex concentrate (4F-PCC), which contains the human coagulation factors II, VII, IX and X together with the endogenous inhibitor proteins S and C, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by VKA (e.g. warfarin or coumarin) therapy in adult
Highlights
The global 4 Factor Pro-thrombin Complex Concentrate market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for 4 Factor Pro-thrombin Complex Concentrate is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 4 Factor Pro-thrombin Complex Concentrate is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of 4 Factor Pro-thrombin Complex Concentrate include CSL Behring, Octapharma, Prothya Biosolutions and Takeda, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 4 Factor Pro-thrombin Complex Concentrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 4 Factor Pro-thrombin Complex Concentrate.
The 4 Factor Pro-thrombin Complex Concentrate market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 4 Factor Pro-thrombin Complex Concentrate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 4 Factor Pro-thrombin Complex Concentrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
CSL Behring
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 4 Factor Pro-thrombin Complex Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 4 Factor Pro-thrombin Complex Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 4 Factor Pro-thrombin Complex Concentrate Market Overview
1.1 Product Overview and Scope of 4 Factor Pro-thrombin Complex Concentrate
1.2 4 Factor Pro-thrombin Complex Concentrate Segment by Type
1.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Market Value Comparison by Type (2025-2031)
1.2.2 Beriplex
1.2.3 Octaplex
1.2.4 Prothromplex
1.2.5 Cofact
1.2.6 Other
1.3 4 Factor Pro-thrombin Complex Concentrate Segment by Application
1.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Market Value by Application: (2025-2031)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global 4 Factor Pro-thrombin Complex Concentrate Market Size Estimates and Forecasts
1.4.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue 2020-2031
1.4.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales 2020-2031
1.4.3 Global 4 Factor Pro-thrombin Complex Concentrate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 4 Factor Pro-thrombin Complex Concentrate Market Competition by Manufacturers
2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Manufacturers (2020-2025)
2.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 4 Factor Pro-thrombin Complex Concentrate Average Price by Manufacturers (2020-2025)
2.4 Global 4 Factor Pro-thrombin Complex Concentrate Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of 4 Factor Pro-thrombin Complex Concentrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 4 Factor Pro-thrombin Complex Concentrate, Product Type & Application
2.7 4 Factor Pro-thrombin Complex Concentrate Market Competitive Situation and Trends
2.7.1 4 Factor Pro-thrombin Complex Concentrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 4 Factor Pro-thrombin Complex Concentrate Players Market Share by Revenue
2.7.3 Global 4 Factor Pro-thrombin Complex Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 4 Factor Pro-thrombin Complex Concentrate Retrospective Market Scenario by Region
3.1 Global 4 Factor Pro-thrombin Complex Concentrate Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global 4 Factor Pro-thrombin Complex Concentrate Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2020-2031
3.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2020-2025
3.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2026-2031
3.3 Global 4 Factor Pro-thrombin Complex Concentrate Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2020-2031
3.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2020-2025
3.3.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2026-2031
3.4 North America 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.4.1 North America 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2031)
3.4.3 North America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.5.1 Europe 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2031)
3.5.3 Europe 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.6.1 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2031)
3.6.3 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.7.1 Latin America 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2031)
3.7.3 Latin America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.8.1 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2031)
3.8.3 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2020-2031)
4.1.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2020-2025)
4.1.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2026-2031)
4.1.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2020-2031)
4.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2020-2031)
4.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2020-2025)
4.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2026-2031)
4.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2020-2031)
4.3 Global 4 Factor Pro-thrombin Complex Concentrate Price by Type (2020-2031)
5 Segment by Application
5.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2020-2031)
5.1.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2020-2025)
5.1.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2026-2031)
5.1.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2020-2031)
5.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2020-2031)
5.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2020-2025)
5.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2026-2031)
5.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2020-2031)
5.3 Global 4 Factor Pro-thrombin Complex Concentrate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Octapharma
6.2.1 Octapharma Corporation Information
6.2.2 Octapharma Description and Business Overview
6.2.3 Octapharma 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Octapharma 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.2.5 Octapharma Recent Developments/Updates
6.3 Prothya Biosolutions
6.3.1 Prothya Biosolutions Corporation Information
6.3.2 Prothya Biosolutions Description and Business Overview
6.3.3 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.3.5 Prothya Biosolutions Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.4.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 4 Factor Pro-thrombin Complex Concentrate Industry Chain Analysis
7.2 4 Factor Pro-thrombin Complex Concentrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 4 Factor Pro-thrombin Complex Concentrate Production Mode & Process
7.4 4 Factor Pro-thrombin Complex Concentrate Sales and Marketing
7.4.1 4 Factor Pro-thrombin Complex Concentrate Sales Channels
7.4.2 4 Factor Pro-thrombin Complex Concentrate Distributors
7.5 4 Factor Pro-thrombin Complex Concentrate Customers
8 4 Factor Pro-thrombin Complex Concentrate Market Dynamics
8.1 4 Factor Pro-thrombin Complex Concentrate Industry Trends
8.2 4 Factor Pro-thrombin Complex Concentrate Market Drivers
8.3 4 Factor Pro-thrombin Complex Concentrate Market Challenges
8.4 4 Factor Pro-thrombin Complex Concentrate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global 4 Factor Pro-thrombin Complex Concentrate Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global 4 Factor Pro-thrombin Complex Concentrate Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global 4 Factor Pro-thrombin Complex Concentrate Market Competitive Situation by Manufacturers in 2024
Table 4. Global 4 Factor Pro-thrombin Complex Concentrate Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Manufacturers (2020-2025)
Table 6. Global 4 Factor Pro-thrombin Complex Concentrate Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market 4 Factor Pro-thrombin Complex Concentrate Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of 4 Factor Pro-thrombin Complex Concentrate, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of 4 Factor Pro-thrombin Complex Concentrate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of 4 Factor Pro-thrombin Complex Concentrate, Product Type & Application
Table 12. Global Key Manufacturers of 4 Factor Pro-thrombin Complex Concentrate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global 4 Factor Pro-thrombin Complex Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 4 Factor Pro-thrombin Complex Concentrate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global 4 Factor Pro-thrombin Complex Concentrate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2020-2025) & (Units)
Table 18. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Region (2020-2025)
Table 19. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2026-2031) & (Units)
Table 20. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Region (2026-2031)
Table 21. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Region (2020-2025)
Table 23. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Region (2026-2031)
Table 25. North America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2025) & (Units)
Table 27. North America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2026-2031) & (Units)
Table 28. North America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe 4 Factor Pro-thrombin Complex Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2025) & (Units)
Table 32. Europe 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2026-2031) & (Units)
Table 33. Europe 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2025) & (Units)
Table 42. Latin America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2026-2031) & (Units)
Table 43. Latin America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2020-2025) & (Units)
Table 47. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2026-2031) & (Units)
Table 48. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global 4 Factor Pro-thrombin Complex Concentrate Sales (Units) by Type (2020-2025)
Table 51. Global 4 Factor Pro-thrombin Complex Concentrate Sales (Units) by Type (2026-2031)
Table 52. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2020-2025)
Table 53. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2026-2031)
Table 54. Global 4 Factor Pro-thrombin Complex Concentrate Revenue (US$ Million) by Type (2020-2025)
Table 55. Global 4 Factor Pro-thrombin Complex Concentrate Revenue (US$ Million) by Type (2026-2031)
Table 56. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2020-2025)
Table 57. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2026-2031)
Table 58. Global 4 Factor Pro-thrombin Complex Concentrate Price (US$/Unit) by Type (2020-2025)
Table 59. Global 4 Factor Pro-thrombin Complex Concentrate Price (US$/Unit) by Type (2026-2031)
Table 60. Global 4 Factor Pro-thrombin Complex Concentrate Sales (Units) by Application (2020-2025)
Table 61. Global 4 Factor Pro-thrombin Complex Concentrate Sales (Units) by Application (2026-2031)
Table 62. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2020-2025)
Table 63. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2026-2031)
Table 64. Global 4 Factor Pro-thrombin Complex Concentrate Revenue (US$ Million) by Application (2020-2025)
Table 65. Global 4 Factor Pro-thrombin Complex Concentrate Revenue (US$ Million) by Application (2026-2031)
Table 66. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2020-2025)
Table 67. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2026-2031)
Table 68. Global 4 Factor Pro-thrombin Complex Concentrate Price (US$/Unit) by Application (2020-2025)
Table 69. Global 4 Factor Pro-thrombin Complex Concentrate Price (US$/Unit) by Application (2026-2031)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring 4 Factor Pro-thrombin Complex Concentrate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSL Behring 4 Factor Pro-thrombin Complex Concentrate Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Octapharma Corporation Information
Table 76. Octapharma Description and Business Overview
Table 77. Octapharma 4 Factor Pro-thrombin Complex Concentrate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Octapharma 4 Factor Pro-thrombin Complex Concentrate Product
Table 79. Octapharma Recent Developments/Updates
Table 80. Prothya Biosolutions Corporation Information
Table 81. Prothya Biosolutions Description and Business Overview
Table 82. Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Product
Table 84. Prothya Biosolutions Recent Developments/Updates
Table 85. Takeda Corporation Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda 4 Factor Pro-thrombin Complex Concentrate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Takeda 4 Factor Pro-thrombin Complex Concentrate Product
Table 89. Takeda Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. 4 Factor Pro-thrombin Complex Concentrate Distributors List
Table 93. 4 Factor Pro-thrombin Complex Concentrate Customers List
Table 94. 4 Factor Pro-thrombin Complex Concentrate Market Trends
Table 95. 4 Factor Pro-thrombin Complex Concentrate Market Drivers
Table 96. 4 Factor Pro-thrombin Complex Concentrate Market Challenges
Table 97. 4 Factor Pro-thrombin Complex Concentrate Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 4 Factor Pro-thrombin Complex Concentrate
Figure 2. Global 4 Factor Pro-thrombin Complex Concentrate Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global 4 Factor Pro-thrombin Complex Concentrate Market Share by Type in 2024 & 2031
Figure 4. Beriplex Product Picture
Figure 5. Octaplex Product Picture
Figure 6. Prothromplex Product Picture
Figure 7. Cofact Product Picture
Figure 8. Other Product Picture
Figure 9. Global 4 Factor Pro-thrombin Complex Concentrate Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 10. Global 4 Factor Pro-thrombin Complex Concentrate Market Share by Application in 2024 & 2031
Figure 11. Hemophilia B
Figure 12. Acquired Coagulation Factor Deficiency
Figure 13. Global 4 Factor Pro-thrombin Complex Concentrate Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global 4 Factor Pro-thrombin Complex Concentrate Market Size (2020-2031) & (US$ Million)
Figure 15. Global 4 Factor Pro-thrombin Complex Concentrate Sales (2020-2031) & (Units)
Figure 16. Global 4 Factor Pro-thrombin Complex Concentrate Average Price (US$/Unit) & (2020-2031)
Figure 17. 4 Factor Pro-thrombin Complex Concentrate Report Years Considered
Figure 18. 4 Factor Pro-thrombin Complex Concentrate Sales Share by Manufacturers in 2024
Figure 19. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest 4 Factor Pro-thrombin Complex Concentrate Players: Market Share by Revenue in 2024
Figure 21. 4 Factor Pro-thrombin Complex Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 22. Global 4 Factor Pro-thrombin Complex Concentrate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2020-2031)
Figure 24. North America 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Country (2020-2031)
Figure 25. United States 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2020-2031)
Figure 28. Europe 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Country (2020-2031)
Figure 29. Germany 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Region (2020-2031)
Figure 36. China 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2020-2031)
Figure 46. Latin America 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Country (2020-2031)
Figure 47. Mexico 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Colombia 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2020-2031)
Figure 52. Middle East & Africa 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Country (2020-2031)
Figure 53. Turkey 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE 4 Factor Pro-thrombin Complex Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of 4 Factor Pro-thrombin Complex Concentrate by Type (2020-2031)
Figure 57. Global Revenue Market Share of 4 Factor Pro-thrombin Complex Concentrate by Type (2020-2031)
Figure 58. Global 4 Factor Pro-thrombin Complex Concentrate Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of 4 Factor Pro-thrombin Complex Concentrate by Application (2020-2031)
Figure 60. Global Revenue Market Share of 4 Factor Pro-thrombin Complex Concentrate by Application (2020-2031)
Figure 61. Global 4 Factor Pro-thrombin Complex Concentrate Price (US$/Unit) by Application (2020-2031)
Figure 62. 4 Factor Pro-thrombin Complex Concentrate Value Chain
Figure 63. 4 Factor Pro-thrombin Complex Concentrate Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

※参考情報

4因子プロトロンビン複合体濃縮物（4 Factor Pro-thrombin Complex Concentrate）は、主に抗凝固剤の影響を受けて出血が生じた患者に対して使用される治療薬です。その主成分は、血液凝固に関与する4つの因子であり、具体的にはプロトロンビン（因子II）、および因子VII、IX、Xが含まれています。これらの因子は、血液凝固の連鎖反応において重要な役割を果たし、出血時の速やかな止血に寄与します。

4因子プロトロンビン複合体濃縮物は、通常、冷凍血漿から抽出または濃縮されます。この製品は、出血が重大なリスクを伴う外科的手術や抗凝固剤の使用後に、迅速に出血をコントロールするための手段として利用されます。特に、ワルファリンなどの抗凝固薬による過剰な抗凝固効果を逆転させるために用いられることが多いです。

この濃縮物の特徴としては、まず速やかに作用する点です。血液中に投与されると、数分以内に凝固因子のレベルを上昇させ、出血を迅速に止めることができます。また、比較的少量で効果を発揮するため、患者への負担が少なく済むという利点もあります。さらに、精製度が高く、不純物が少ないため、使用時の副作用のリスクが減少します。

4因子プロトロンビン複合体濃縮物の主な用途は、抗凝固療法を行っている患者の出血管理です。特に、ワルファリンや他のビタミンK拮抗薬の投与を受けている患者において、出血が生じた場合には、迅速に因子を補充する必要があるため、この製品が大いに役立ちます。また、外科手術や侵襲的手技においても、出血を防ぐための予防的な使用が行われることがあります。さらに、特定の病状においては、予期せぬ出血に対する緊急時の治療としても利用されます。

種類としては、商業的にはいくつかの製品が存在しており、それぞれ特定の特性がある場合がありますが、基本的には含まれる凝固因子の構成や濃度の違いによって分類されます。これらの製品は、主に病院や救急医療において使用され、医療従事者による慎重な管理のもとで投与されます。

関連技術には、製品の製造過程や品質管理が含まれます。4因子プロトロンビン複合体濃縮物は、厳密な製造プロセスを経て品質が確保されることが求められます。冷凍血漿からの抽出や、特定の精製技術によって、最大限の凝固因子を有効成分として含む製品が作られます。また、新たな技術の導入により、より効率的で効果的な製造プロセスが開発されることが期待されています。さらに、患者の安全性を向上させるための研究も行われており、副作用のリスクを減少させるための新しいアプローチが模索されています。

4因子プロトロンビン複合体濃縮物は、さまざまな医療現場での重要な役割を果たし、出血に関する緊急対応の一助となっています。今後の研究や技術の発展により、さらなる改善が期待される治療法とも言えるでしょう。この製品の進化によって、より多くの患者が恩恵を受け、より安全に治療を受けることができる日が来ることを願っています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のヒトプロトロンビン複合体濃縮物市場2023年：企業・地域・タイプ・用途別分析
  • 局所トロンビンのグローバル市場2023：ウシ系、ヒト系、その他
  • トロンビン調製剤のグローバル市場2023：線溶阻害剤、血小板凝集阻害剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8650 )"4因子プロトロンビン複合体濃縮物の世界市場2025年：Beriplex、Octaplex、Prothromplex、Cofact、その他" (英文：Global 4 Factor Pro-thrombin Complex Concentrate Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。